Biotech sold a patent on a new blood analyzer to Pharma. The sales agreement which was signed on January 1, 2019, requires Pharma to pay Biotech $1 million immediately. In addition, Pharma is required to pay $700,000 each December 31 for 20 years starting with December 31, 2019. Pharma and Biotech judge that a 9 percent is an appropriate interest rate for this arrangement.

(a) Compute the present value of the receivable on Biotechs books on January 1, 2019 immediately after receiving the $1 million down payment.

(b) Compute the present value of the receivable on Biotechs books on December 31, 2019

(c) Compute the present value of the receivable on Biotechs books on December 31, 2020

(Please show work)